✦ LIBER ✦

Re: Economic Evaluation of Denosumab Compared With Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients With Bone Metastases

✍ Scribed by Hans-Peter Schmid; Robert Theiler

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Denosumab Compared

✍ Jipan Xie; Melissa Diener; Rachael Sorg; Eric Q. Wu; Madhav Namjoshi 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 544 KB

The risk of renal impairment in hormone-

✍ William K. Oh; Kevin Proctor; Mari Nakabayashi; Carolyn Evan; Lauren K. Tormey; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Combined use of zoledronic acid and 153S

✍ Marnix G. E. H. Lam; Amel Dahmane; Wil H. M. Stevens; Peter P. van Rijk; John M. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 243 KB

Benefit of Extended Zoledronate Therapy

✍ Price, Nancy; Sartor, Oliver; Jain, Vinay K. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 98 KB

Multimodality treatment in hormone-refra

✍ Marnix G. E. H. Lam; Bernard A. Zonnenberg 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 75 KB

Docetaxel and zoledronic acid in patient

✍ Dimitri Vordos; Bernard Paule; Francis Vacherot; Yves Allory; Laurent Salomon; A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB